FR2374043A1 - Infusions en solution contenant du glucose et des kinines, destinees en particulier a l'alimentation parenterale - Google Patents

Infusions en solution contenant du glucose et des kinines, destinees en particulier a l'alimentation parenterale

Info

Publication number
FR2374043A1
FR2374043A1 FR7738032A FR7738032A FR2374043A1 FR 2374043 A1 FR2374043 A1 FR 2374043A1 FR 7738032 A FR7738032 A FR 7738032A FR 7738032 A FR7738032 A FR 7738032A FR 2374043 A1 FR2374043 A1 FR 2374043A1
Authority
FR
France
Prior art keywords
infusions
intended
solution containing
kinines
containing glucose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7738032A
Other languages
English (en)
Other versions
FR2374043B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Thera Patent GmbH and Co KG Gesellschaft fuer Industrielle Schutzrechte
Original Assignee
Thera Patent GmbH and Co KG Gesellschaft fuer Industrielle Schutzrechte
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thera Patent GmbH and Co KG Gesellschaft fuer Industrielle Schutzrechte filed Critical Thera Patent GmbH and Co KG Gesellschaft fuer Industrielle Schutzrechte
Publication of FR2374043A1 publication Critical patent/FR2374043A1/fr
Application granted granted Critical
Publication of FR2374043B1 publication Critical patent/FR2374043B1/fr
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/043Kallidins; Bradykinins; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Infusions en solution contenant du glucose, destinées en particulier à l'alimentation parentérale. L'infusion selon l'invention est caractérisée en ce qu'elle contient des kinines à raison de 10 à 3000 mu g par litre. Application à l'alimentation parentérale.
FR7738032A 1976-12-17 1977-12-16 Infusions en solution contenant du glucose et des kinines, destinees en particulier a l'alimentation parenterale Granted FR2374043A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2657381A DE2657381C2 (de) 1976-12-17 1976-12-17 Glucosehaltige Infusionslösung

Publications (2)

Publication Number Publication Date
FR2374043A1 true FR2374043A1 (fr) 1978-07-13
FR2374043B1 FR2374043B1 (fr) 1982-06-11

Family

ID=5995850

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7738032A Granted FR2374043A1 (fr) 1976-12-17 1977-12-16 Infusions en solution contenant du glucose et des kinines, destinees en particulier a l'alimentation parenterale

Country Status (12)

Country Link
US (1) US4152425A (fr)
JP (1) JPS5914006B2 (fr)
AT (1) ATA904977A (fr)
AU (1) AU517454B2 (fr)
CA (1) CA1077845A (fr)
CH (1) CH638400A5 (fr)
DE (1) DE2657381C2 (fr)
FR (1) FR2374043A1 (fr)
GB (1) GB1545743A (fr)
IE (1) IE46281B1 (fr)
NL (1) NL7713961A (fr)
SE (1) SE442480B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH639247A5 (de) * 1979-01-23 1983-11-15 Thera Ges Fuer Patente Aminosaeuren und mineralsalze enthaltende infusionsloesung.
US5385940A (en) * 1992-11-05 1995-01-31 The General Hospital Corporation Treatment of stroke with nitric-oxide releasing compounds
US20020076782A1 (en) * 1996-07-05 2002-06-20 John P.N. Rosazza Purified nitric oxide synthase

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2357507A1 (de) * 1973-11-17 1975-05-28 Bayer Ag Mittel zur fertilitaetssteigerung
FR2374044A1 (fr) * 1976-12-17 1978-07-13 Thera Ges Fuer Patente Agent anti-diabetique oral contenant une sulfonyluree et une kinine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE352533B (fr) * 1967-10-20 1973-01-08 Sandoz Ag

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2357507A1 (de) * 1973-11-17 1975-05-28 Bayer Ag Mittel zur fertilitaetssteigerung
FR2374044A1 (fr) * 1976-12-17 1978-07-13 Thera Ges Fuer Patente Agent anti-diabetique oral contenant une sulfonyluree et une kinine

Also Published As

Publication number Publication date
SE7714359L (sv) 1978-06-18
DE2657381A1 (de) 1978-06-29
AU3175877A (en) 1979-06-28
SE442480B (sv) 1986-01-13
CH638400A5 (de) 1983-09-30
NL7713961A (nl) 1978-06-20
AU517454B2 (en) 1981-07-30
IE46281B1 (en) 1983-04-20
FR2374043B1 (fr) 1982-06-11
CA1077845A (fr) 1980-05-20
GB1545743A (en) 1979-05-16
JPS5386010A (en) 1978-07-29
JPS5914006B2 (ja) 1984-04-02
IE46281L (en) 1978-06-17
US4152425A (en) 1979-05-01
DE2657381C2 (de) 1982-03-25
ATA904977A (de) 1979-05-15

Similar Documents

Publication Publication Date Title
NO20005565D0 (no) Preparater med konjugert linolsyre anriket med isomerer
DE69133347D1 (de) Plasmide, die die DNA-Sequenzen für die Veränderung des Kohlehydrat- und Proteingehalts bzw. Komposition in Pflanzen enthalten, sowie diese Plasmide enthaltende Pflanzen und Pflanzenzellen
ES8203324A1 (es) Procedimiento para la fabricacion de compuestos antitumora- les a base de platino
ES8504672A1 (es) Un complejo de dideptido edulcorante-metal.
IL140848A (en) Pharmaceutical compositions containing phenylacetylglutamine, phenylacetylisoglutamine and/or phenylacetate
FR2426463A1 (fr) Preparation therapeutique destinee a l'administration parenterale de triglycerides contenant de l'acyl-carnitine
SG102892G (en) Composition of pregnanolole comprising a stable oil-in-water emulsion
FR2374043A1 (fr) Infusions en solution contenant du glucose et des kinines, destinees en particulier a l'alimentation parenterale
JPS6434909A (en) Cosmetic
ATE211908T1 (de) Intravenöse lösung, die den protein - und wasserverlust im körper reduziert
MY102003A (en) Novel derivatives of 4, 5-dihydrooxazoles, a process for their preparation, and their use.
KR900003187A (ko) 백금(ⅳ)-디아민 착물, 이 화합물의 제조방법, 최소한 하나의 백금 화합물을 포함하는 항종양 활성을 갖고 있는 제제, 항종양 활성을 갖고있는 제형화된 제제
GB1336419A (en) Compound for the treatment of cardiovascular disorders and pharmaceutical compositions containing the same
GB1530138A (en) Pharmaceutical composition
DE59005128D1 (de) t-PA pro STABILISIERUNG.
JPS55113721A (en) Immunity regulator
RU94025008A (ru) Противоопухолевое средство
ES377523A1 (es) Un procedimiento para fabricar una sustancia combinada, compuesta de acido germanico y cisteina.
GB1327467A (en) Pharmaceutical compositions for inhibiting indoleamine- n-methyl transferase
KR920700683A (ko) t-PA의 가용화
Kovrizhnykh et al. The Decomposition Rate of Organic Matter of Stephanodiscus Hantzschii Grun. From the Channel of the Northern Donets Basin,(In Russian)
ES449610A1 (es) Un procedimiento de preparacion de compuestos derivados de la midecamicina.
GB1461558A (en) Spasmium salt
KR920701221A (ko) 신규한 백금 착체 및 이를 유효성분으로 하는 항종양제
Kudsk et al. Effect of route of nutrient administration on survival with hemoglobin-Escherichia coli adjuvant peritonitis in normal rats.

Legal Events

Date Code Title Description
CA Change of address
CD Change of name or company name
ST Notification of lapse